Abstract | PURPOSE: MATERIALS AND METHODS: The amelanotic C32 and melanotic COLO829 human melanoma cell lines were exposed to increasing concentrations of psoralens (0.1-100 μM) in the presence or absence of UVA radiation. Cell viability was evaluated by the WST-1 assay. RESULTS: We demonstrated that 8-MOP, in contrast to 5-MOP, has no cytotoxic effect on both melanoma cell lines. Simultaneous exposure of cells to 8-MOP and UVA radiation caused significant cytotoxic response in C32 cells where the EC50 value was estimated to be 131.0 μM (UVA dose: 1.3 J/cm2) and 105.3 μM (UVA dose: 2.6 J/cm2). The cytotoxicity of 5-MOP on both C32 and COLO829 cells was significantly augmented by UVA radiation - the EC50 was estimated to be 22.7 or 7.9 μM (UVA dose: 1.3 J/cm2) and 24.2 or 7.0 μM (UVA dose: 2.6 J/cm2), respectively. CONCLUSIONS: The demonstrated high cytotoxic response after simultaneous exposure of melanoma cells to psoralens and UVA radiation in vitro suggests the usefulness of PUVA therapy to treat melanoma in vivo.
|
Authors | Dorota Wrześniok, Artur Beberok, Jakub Rok, Marcin Delijewski, Anna Hechmann, Martyna Oprzondek, Zuzanna Rzepka, Barbara Bacler-Żbikowska, Ewa Buszman |
Journal | International journal of radiation biology
(Int J Radiat Biol)
Vol. 93
Issue 7
Pg. 734-739
(07 2017)
ISSN: 1362-3095 [Electronic] England |
PMID | 28287037
(Publication Type: Journal Article)
|
Chemical References |
- 5-Methoxypsoralen
- Methoxsalen
|
Topics |
- 5-Methoxypsoralen
- Cell Line, Tumor
- Cell Survival
(drug effects, radiation effects)
- Dose-Response Relationship, Drug
- Dose-Response Relationship, Radiation
- Drug Synergism
- Humans
- Melanoma
(drug therapy, pathology)
- Methoxsalen
(administration & dosage, analogs & derivatives)
- PUVA Therapy
(methods)
- Radiotherapy Dosage
- Treatment Outcome
|